68 related articles for article (PubMed ID: 31441359)
1. ROR1 and ROR2-novel targets for neuroblastoma.
Dave H; Butcher D; Anver M; Bollard CM
Pediatr Hematol Oncol; 2019 Sep; 36(6):352-364. PubMed ID: 31441359
[No Abstract] [Full Text] [Related]
2. Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.
Tibbetts R; Yeo KK; Muthugounder S; Lee MH; Jung C; Porras-Corredor T; Sheard MA; Asgharzadeh S
Cancer Immunol Immunother; 2022 Jan; 71(1):153-164. PubMed ID: 34043024
[TBL] [Abstract][Full Text] [Related]
3. Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
Parker BA; Shatsky RA; Schwab RB; Wallace AM; ; Wolf DM; Hirst GL; Brown-Swigart L; Esserman LJ; van 't Veer LJ; Ghia EM; Yau C; Kipps TJ
Breast Cancer Res Treat; 2023 Jun; 199(2):281-291. PubMed ID: 37029329
[TBL] [Abstract][Full Text] [Related]
4. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.
Raivola J; Dini A; Salokas K; Karvonen H; Niininen W; Piki E; Varjosalo M; Ungureanu D
Cell Mol Life Sci; 2022 May; 79(5):276. PubMed ID: 35504983
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Receptor Tyrosine Kinase-Like Orphan Receptors in Intestinal-Type Gastric Cancer.
Nema R; Patel P; Kumar A
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2125-2134. PubMed ID: 34319035
[TBL] [Abstract][Full Text] [Related]
6. Role of the Ror family receptors in Wnt5a signaling.
Kamizaki K; Minami Y; Nishita M
In Vitro Cell Dev Biol Anim; 2024 Apr; ():. PubMed ID: 38587578
[TBL] [Abstract][Full Text] [Related]
7. Exploration of macrocyclic peptide binders to the extracellular CRD domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1).
Qiao JX; Witmer MR; Lee V; Wang TC; Reid PC; Arioka Y; Farr G; Hill-Drzewi M; Schweizer L; Yamniuk A; Cheng L; Abramczyk B; Corbett M; Calambur D; Szapiel N; Ryseck R; Ponath P; Poss MA; Carter P
Bioorg Med Chem Lett; 2024 Jan; 98():129589. PubMed ID: 38097140
[TBL] [Abstract][Full Text] [Related]
8. Role of Wnt5b-Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells.
Yamauchi N; Otsuka M; Ishikawa T; Kakeji Y; Kikuchi A; Masuda A; Kodama Y; Minami Y; Kamizaki K
Genes Cells; 2024 Mar; ():. PubMed ID: 38531660
[TBL] [Abstract][Full Text] [Related]
9. Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions.
Zheng M; Kumar A; Sharma V; Behl T; Sehgal A; Wal P; Shinde NV; Kawaduji BS; Kapoor A; Anwer MK; Gulati M; Shen B; Singla RK; Bungau SG
Front Cell Dev Biol; 2024; 12():1353860. PubMed ID: 38601081
[TBL] [Abstract][Full Text] [Related]
10. Correction: Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2.
Cancer Discov; 2023 Nov; 13(11):2488. PubMed ID: 37909094
[No Abstract] [Full Text] [Related]
11. Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications.
Goydel RS; Weber J; Peng H; Qi J; Soden J; Freeth J; Park H; Rader C
J Biol Chem; 2020 May; 295(18):5995-6006. PubMed ID: 32193207
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal Antibody Against ROR1 Induces Apoptosis in Human Bladder Carcinoma Cells.
Bayat AA; Sadeghi N; Fatemi R; Nowroozi MR; Ohadian Moghadam S; Borzuee M; Radmanesh A; Khodadoost M; Sarrafzadeh AR; Zarei O; Rabbani H
Avicenna J Med Biotechnol; 2020; 12(3):165-171. PubMed ID: 32695279
[TBL] [Abstract][Full Text] [Related]
13. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
Patel S; Alam A; Pant R; Chattopadhyay S
Front Immunol; 2019; 10():2872. PubMed ID: 31921137
[TBL] [Abstract][Full Text] [Related]
14. Functional and clinical significance of ROR1 in lung adenocarcinoma.
Schiavone G; Epistolio S; Martin V; Molinari F; Barizzi J; Mazzucchelli L; Frattini M; Wannesson L
BMC Cancer; 2020 Nov; 20(1):1085. PubMed ID: 33172431
[TBL] [Abstract][Full Text] [Related]
15. Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.
Sheetz JB; Mathea S; Karvonen H; Malhotra K; Chatterjee D; Niininen W; Perttilä R; Preuss F; Suresh K; Stayrook SE; Tsutsui Y; Radhakrishnan R; Ungureanu D; Knapp S; Lemmon MA
Mol Cell; 2020 Aug; 79(3):390-405.e7. PubMed ID: 32619402
[TBL] [Abstract][Full Text] [Related]
16. Targeting ROR1 in combination with pemetrexed in malignant mesothelioma cells.
Miyake N; Ochi N; Yamane H; Fukazawa T; Ikeda T; Yokota E; Takeyama M; Nakagawa N; Nakanishi H; Kohara H; Nagasaki Y; Kawahara T; Ichiyama N; Yamatsuji T; Naomoto Y; Takigawa N
Lung Cancer; 2020 Jan; 139():170-178. PubMed ID: 31809978
[TBL] [Abstract][Full Text] [Related]
17. Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis.
Hasan MK; Widhopf GF; Zhang S; Lam SM; Shen Z; Briggs SP; Parker BA; Kipps TJ
NPJ Breast Cancer; 2019; 5():35. PubMed ID: 31667337
[TBL] [Abstract][Full Text] [Related]
18. A fully chimeric IgG antibody for ROR1 suppresses ovarian cancer growth in vitro and in vivo.
Yin Z; Mao Y; Zhang N; Su Y; Zhu J; Tong H; Zhang H
Biomed Pharmacother; 2019 Nov; 119():109420. PubMed ID: 31536932
[TBL] [Abstract][Full Text] [Related]
19. ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models.
Vaisitti T; Arruga F; Vitale N; Lee TT; Ko M; Chadburn A; Braggio E; Di Napoli A; Iannello A; Allan JN; Miller LL; Lannutti BJ; Furman RR; Jessen KA; Deaglio S
Blood; 2021 Jun; 137(24):3365-3377. PubMed ID: 33512452
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
